The ImPrEP LEN Brasil study, investigating lenacapavir for pre-exposure prophylaxis of HIV in young adults across seven Brazilian cities, was launched in January, 2026. Tony Kirby reports.
The Lancet Infectious Diseases published a clinical update in Infectious Disease on 01 Apr 2026.
The item focuses on Brazil launches implementation study of lenacapavir.
Review the original article for the full source wording and details.